期刊文献+

Ⅰ期细支气管肺泡癌与腺癌临床分析比较 被引量:3

Clinical analysis in patients with stage Ⅰ bronchioloalveolar carcinoma and adenocarcinoma
下载PDF
导出
摘要 目的:探讨Ⅰ期细支气管肺泡癌(bronchioloalveolar carcinoma,BAC)和腺癌的临床特点及预后因素。方法:对于在我院接受手术的67例Ⅰ期细支气管肺泡癌和190例Ⅰ期腺癌的临床资料进行对比分析。结果:Ⅰ期BAC和腺癌的发生在性别(P=0·005)和是否吸烟(P=0·015)差异有统计学意义。影像学表现方面,二者出现分叶征(P=0·024)、空泡征(P=0·014)和磨玻璃征(P=0·000)的概率差异有统计学意义。Ⅰ期BAC和腺癌术后5年生存率分别为68·0%、46·0%,差异有统计学意义,P=0·0043。BAC男性患者术后5年生存率高于女性(P=0·035),而肺腺癌女性患者术后5年生存率高于男性(P=0·027);手术方式与BAC预后无关联,而腺癌行肺叶切除术的患者5年生存率高于肺段切除术的患者(P=0·040);吸烟与两者的预后均无关联。结论:Ⅰ期BAC女性患者多于男性,与吸烟无明显相关性,标准术式为肺叶切除+淋巴结清除术,预后优于腺癌,且男性优于女性。 OBJECTIVE:To compare the clinic characteristics and prognostic factors in patients with stage I bronchioloalveolar carcinoma (BAC) and adenocarcinoma of the lung. METHODS: Clinic data of 257 inpatient cases with stage I BAC and adenocarcinoma in The Cancer Hospital of Tianjin Medical University, were retrospectively reviewed. We made a comparion between the two groups. RESULTS: Stage Ⅰ BAC and adenocarcinoma have apparent differences in gender (P = 0. 005) and smoking ( P = 0. 015 ), and they have different imaging characteristics. The 5-year survival rate of Stage Ⅰ BAC (68. 0%) was higher than that of adenocarcinoma (46. 0%),P=0. 0043. The 5-year survival rate of male was higher than female with BAC (P=0. 035),while the 5-year survival rate of female was higher than male with adenocarcinoma, P = 0. 027. The surgical methods have no impact on the 5-year survival rate of Stage Ⅰ BAC, while the surgical methods have apparent impact on the 5-year survival rate of Stage Ⅰ adenocarcinoma, P = 0. 040. Smoking has no impact on the 5-year survival rate of Stage Ⅰ BAC and adenocarcinoma. CONCLUSIONS: Stage Ⅰ bronchioloalveolar carcinoma is more likely to occure in female. No obvious relation is found with smoking. Lobectomy is performed as standard method in its surgical treatment. The prognosis with BAC is superior to adenocarcinoma, and the prognosis of male is superior to female.
出处 《中华肿瘤防治杂志》 CAS 2007年第12期939-941,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 腺癌 细支气管肺泡 临床对照研究 预后 adenocarcinoma, bronchiolo-alveolar case-control studies prognosis
  • 相关文献

参考文献6

  • 1Jackman D M,Chirieac L R,Janne P A.Bronchioloalveolar carcinoma:a review of the epidemiology,pathology,and treatment[J].Semin Respir Crit Care Med,2005,26(3):342-352.
  • 2Furak J,Trojan I,Szoke T,et al.Bronchioloalveolar lung cancer:occurrence,surgical treatment and survival[J].Eur J Cardiothorac Surg,2003,23(5):818-823.
  • 3Rena O,Papalia E,Ruffini E,et al.Stage I pure bronchioloalveolar carcinoma:recurrences,survival and comparison with adenocarcinoma of the lung[J].Eur J Cardiothorac Surg,2003,23(3):409-414.
  • 4张灿斌,徐中一,张克.Ⅰ期细支气管肺泡癌和腺癌的临床对比分析[J].中国肿瘤临床,2004,31(1):33-35. 被引量:10
  • 5Hsu C P,Chen C Y,Hsu N Y,et al.Bronchioloalveolar carcinoma[J].J Thorac Cardiovasc Surg,1995,110(2):374-381.
  • 6Damhuis R A,Schutte P R,Varin O C,et al.Poor results after surgery for bronchioloalveolar carcinoma[J].Eur J Surg Oncol,2006,32(5):573-576.

二级参考文献1

共引文献9

同被引文献49

  • 1田庆,韦立新,曹友俊,陈良安.肺癌中细支气管肺泡癌构成比的变化分析[J].中华肿瘤防治杂志,2007,14(7):497-499. 被引量:5
  • 2Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol, 2005, 40(2): 90-97.
  • 3Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev, 2000, 14(11): 1343-1352.
  • 4Radtke F, Schweisguth F, Pear W. The Notch "gospel". EMBO Rep, 2005, 6(12): 1120-1125.
  • 5Gridley T. Vascular biology: vessel guidance. Nature, 2007, 445(7129): 722-723.
  • 6Patel NS, Dobbie MS, Rochester M, et aL Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res, 2006, 12(16): 4836-4844.
  • 7Thurston G, Kitajewski J. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer, 2008, 99(8): 1204-1209.
  • 8Patel NS, Li JL, Generali D, et al. Up-regulation of deha-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res, 2005, 65(19): 8690-8697.
  • 9Liu Z J, Shirakawa T, Li Y, et al. Regulation of Notehl and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol, 2003, 23(1): 14-25.
  • 10Li JL, Sainson RC, Shi W, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res, 2007, 67(23): 11244-11253.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部